- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01785173
Endoscopic-guided Versus Cotton-tipped Applicator Gauze Pledgetting for Nasal Anesthesia Before Transnasal Endoscopy
A Randomized Study Comparing Endoscopic-guided Gauze Pledgetting and Cotton-tipped Applicator Packing for Nasal Anesthesia Before Transnasal Endoscopy
Unsedated transnasal esophago-gastro-duodenoscopy (UT-EGD) has gained wide popularity and is one of the most frequently performed diagnostic procedures in Japan and Europe. The technique of using a cotton pledget soaked with lignocaine and decongestant is quite effective but does cause some discomfort during application of anesthetic agent to the nasal cavity. Hence, an effective method to deliver anesthetic agent, using a minimal dose of drugs, and at the same time maintain a good field of vision during endoscopy are all very important.
Using a cotton-tippled applicator to deliver a soaked gauze strip may cause kinking of it around the nasal vestibule or just in the anterior end of a turbinate. Endoscopic guidance to deliver a gauze strip can confirm delivering it to at least the posterior end of a turbinate. We hypothesize that a simple endoscopic-guided gauze pledgetting method is more tolerable than the "blind" cotton-tippled applicator method to deliver a gauze strip for anesthetizing the nasal cavity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Nasal anesthesia is the rate-limiting step for a well tolerable unsedated transnasal esophago-gastro-duodenoscopy (UT-EGD) procedure. The technique of using a cotton pledget soaked with lignocaine and decongestant is quite effective but does cause some discomfort during application of a cotton pledget to the nasal cavity. Hence, an effective method to deliver anesthetic agent and maintain a good field of vision during endoscopy are all very important.
Using a cotton-tippled applicator to deliver a soaked gauze strip may cause kinking of it around the nasal vestibule or just in the anterior end of a turbinate. Endoscopic guidance to deliver a gauze strip can confirm delivering it to at least the posterior end of a turbinate. We propose that a simple Endoscopic-Guided Gauze Pledgetting method (EGGP) is more tolerable than the "blind" cotton-tippled applicator method to deliver a gauze strip for anesthetizing the nasal cavity.
We hypothesize that this method can deliver a gauze strip to the superior end of a turbinate, thus inducing more adequate nasal anesthesia and reducing nasal pain. Hence, the primary objective of this study was to evaluate whether this EGGP method could reduce side effects such as nasal pain and bleeding and improve tolerance associated with UT-EGD. In a large tertiary referral hospital in Taiwan, We are going to conduct a prospective randomized-controlled trial to compare patient tolerance, safety and adverse events between EGGP versus cotton-tipped applicator primed gauze pledgetting (CTGP) methods of nasal anesthesia.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hualien county
-
Hualien City, Hualien county, Taiwan, 970
- Recruiting
- Buddhist Tzu Chi Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All outpatients with epigastric discomfort (non-ulcer dyspepsia),
- aged 18-65 years are eligibility for this study.
Exclusion Criteria:
- Patients who can not answer questionnaires,
- who have prior nasal trauma or surgery, recent or present upper gastrointestinal bleeding and coagulopathy are excluded from this study.
- Patients who are allergic to lidocaine and who have uncontrolled hypertension or coronary artery disease are not recruited.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Endoscopic-guided gauze pledgetting
All patients in the study group receive endoscopic-guided gauze pledgetting (EGGP) nasal anesthesia.
Each patient will receive an anterior rhinoscopy to select the most patent meatus for gauze pledegetting by a validated meatus scoring scale.
The endoscope is preloaded with a 1.8 mm biopsy forceps to pick up the acute angle between the shorter leg and hypotenuse of a right-angled gauze strip (already soaked with anesthesia/decongestant) and retract back just into the biopsy channel.
When the transnasal endoscope tip is set in the nasal vestibule, the preloaded biopsy forceps is protruded slowly into the desired meatus under endoscope monitoring.
A gauze strip is at least brought onto the posterior end of the inferior or middle turbinate.
|
By using a transnasal endoscope as a guide and a biopsy forceps, a gauze strip soaked with decongestant and anesthesia will be delivered to a selected nasal meatus chosen by anterior rhinoscopy.
|
Active Comparator: Cotton-tipped applicator pledgetting
Another randomized group of patients will receive cotton-tipped applicator gauze pledgetting (CTGP) method of nasal anesthesia.
Two cotton-tippled applicators help determine the following: (a) right or left side, (b) inferior or middle nasal meatus (INM or MNM) and (c) the need of local epinephrine.
The investigators apply gently in parallel two sterile 3" x 1/10", double-ended, plastic shaft cotton-tipped applicators, pretreated with minimal amount of 2% viscous lidocaine plus 4% liquid lidocaine, to lubricate and anesthetize the more patent meatus One cotton-tipped applicator is re-used to deliver a triangular gauze strip to the selected meatus during the gauze pledgetting procedure.
|
In contrast to the endoscopic-guided, forceps-delivering method, a gauze strip is delivered to a selected meatus by a cotton-tipped applicator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The primary outcome measures are tolerability profiles on a validated visual analogue scale
Time Frame: Immediately after transnasal endoscopy up to all questionnaires answered (about 15 minutes)
|
The primary outcome measures are tolerability profiles on a validated visual analogue scale (VAS) and difficulty in inserting the transnasal endoscope through a selected meatus based on a Likert scale.
The Likert scale has 5 points of difficulty: minimal, slight, moderate, substantial, and extreme.
Facing a 5-point VAS card (1 = minimal discomfort to 5 = severe discomfort), all patients give real-time feedback immediately after UT-EGD by speaking or pointing out their scorings for the following: (1) pain during anesthesia, (2) pain during nasal insertions, (3) pain during exsertion, and (4) overall tolerance.
|
Immediately after transnasal endoscopy up to all questionnaires answered (about 15 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary outcome measures evaluate the side effects of nasal anesthesia
Time Frame: The immediate secondary outcome measures will be evaluated by questionnaires immediately after UT-EGD and the delayed secondary outcome measures will be evaluated by otolaryngologists within two weeks after UT-EGD.
|
Secondary outcome measures will be evaluated by assisting nurses, who record (a) immediate responses including: (i) epistaxis, (ii) immediately post-procedural side effects including headache, light headiness, and mucous discharge, and (iii) patient's willingness to receive the same procedure the next time, and (b) delayed side effect including (i) persisting nasal discharge, (ii) epistaxis 24 hours after UT-EGD, and (iii) sinusitis all confirmed by otolaryngologists within two weeks after UT-EGD. The visual capacity for the anterior nasal cavity ranking on a 5-point scale (5 represented standard EGD and 1 poor visual quality) is also evaluated by assisting nurses during endoscopic insertion after nasal decongestive anesthesia. |
The immediate secondary outcome measures will be evaluated by questionnaires immediately after UT-EGD and the delayed secondary outcome measures will be evaluated by otolaryngologists within two weeks after UT-EGD.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB101-85
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Methods of Nasal Anesthesia Before Transnasal Endoscopy
-
Chuncheon Sacred Heart HospitalCompletedPretreatment Method of Transnasal EndoscopyKorea, Republic of
-
Buddhist Tzu Chi General HospitalUnknownInjury Due to Endoscopic Examination | Transnasal Endoscopy Induced Epistaxis | Transnasal Endoscopy Induced Nasal PainTaiwan
-
Hospital de Clinicas de Porto AlegreCompletedDeviated Nasal Septum | Nasal Septal Defect | Nasal Septum, IrregularBrazil
-
Fudan UniversityCompletedthe Filling of Jugular Vein Before Anesthesia With and Without Valsalva ManeuverChina
-
DeNova ResearchGalderma R&DCompletedDeformity of Nasal CartilageUnited States
-
Bezmialem Vakif UniversityRecruitingAirway Obstruction | Oxygen Deficiency | Airway Complication of Anesthesia | Anesthesia Complication | Bronchospasm | Nasal Bleeding | Supraglottic Airway ObstructionTurkey
-
Inonu UniversityCompletedAnesthesia Management of Premature InfantsTurkey
-
Centre Hospitalier Universitaire VaudoisCompletedNormal Values of Nasal Nitric Oxide in Healthy AdultsSwitzerland
-
International Centre for Diarrhoeal Disease Research...University of California, Berkeley; University of Maryland; Harvard UniversityCompletedDevelop a New Group Version of the Becker-DeGroot-Marsckek (BDM) Auction to Measure Willingness to Pay of Compound Members for Shared Hardware. | Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social... and other conditionsBangladesh
-
Medical University of ViennaRecruitingCongenital Heart Disease | Airway Complication of AnesthesiaAustria
Clinical Trials on Endoscopic-guided gauze pledgetting
-
Yiqi DuUnknownPancreatic Pseudocyst
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de Bellvitge; Fundació Institut de Recerca... and other collaboratorsCompletedPancreatic Cancer | Endoscopy | Oncologic Disorders | Therapy Related NeoplasmsSpain
-
AdventHealthCompletedPancreatic Neoplasms | Pancreatic Cancer | Pancreatic AdenocarcinomaUnited States
-
Mauna Kea TechnologiesCellvizio Inc.CompletedAdenocarcinoma | Barrett's Esophagus | Barrett Esophagus | Barrett Syndrome | Barrett's SyndromeUnited States, United Kingdom, France
-
Assiut UniversityUnknown
-
University of BolognaCompletedPancreatic Adenocarcinoma | Pancreas Cancer | Pancreas MetastasesItaly
-
National Taiwan University HospitalCompleted
-
Texas Tech University Health Sciences Center, El...TerminatedSolid TumorUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknown